Aripiprazole reverses Paliperidone-induced Hyperprolactinemia

被引：0
|
作者：
Basterreche, Nieves [1 ,2 ]
Zumarraga, Mercedes [3 ]
Arrue, Aurora [3 ]
Olivas, Olga [1 ]
Davila, Wendy
机构：
[1] Hosp Zamudio, Short Stay Unit, Red Salud Mental Bizkaia, Zamudio 48170, Bizkaia, Spain
[2] Univ Basque Country, Dept Psychiat, Fac Med, E-48080 Bilbao, Spain
[3] Hosp Zamudio, Neurochem Res Dept, Red Salud Mental Bizkaia, Zamudio 48170, Bizkaia, Spain
来源：
ACTAS ESPANOLAS DE PSIQUIATRIA | 2012年 / 40卷 / 05期
关键词：
Hyperprolactinemia; Paliperidone; Aripiprazole; ANTIPSYCHOTIC-INDUCED HYPERPROLACTINEMIA; SCHIZOPHRENIA; RISPERIDONE; PROLACTIN; DISORDER;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Hyperprolactinemia is a common side effect of antipsychotic treatments. Existing alternatives to resolve this problem include decreasing the antipsychotic dose or switching to a different antipsychotic agent. Nevertheless, said modifications can sometimes lead to decompensation of the patient. We report a clinical case of a female patient in whom the combined treatment of 5 mg/day of aripiprazole (5 mg/day) reversed paliperidone-induced hyperprolactinemia within four weeks.
引用
收藏
页码：290 / 292
页数：3
相关论文
共 50 条
  • [1] Using aripiprazole to attenuate paliperidone-induced hyperprolactinemia
    Rocha, Fabio Lopes
    Hara, Claudia
    Ramos, Melissa Guarieiro
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (06): : 1153 - 1154
  • [2] Factors affecting the efficacy of adjunctive aripiprazole in risperidone- or paliperidone-induced hyperprolactinemia
    Arnaiz Munoz, A.
    Olivas, O.
    Erkoreka, L.
    Gaton, M. A.
    Barreiro, A.
    Rodriguez, J.
    Arrue, A.
    Basterreche, N.
    Zumarraga, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S125 - S126
  • [3] Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level
    Zhi, Pu
    Wang, Yanqiong
    Quan, Wei
    Su, Yanli
    Zhang, Hui
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018, 14 : 2175 - 2179
  • [4] Adjunctive aripiprazole in the treatment of risperidone/paliperidone-induced hyperprolactinemia. Influence of catechol-O-methyltransferase and MAOA polymorphisms
    Arnaiz, A.
    Zumarraga, M.
    Olivas, O.
    Arrue, A.
    Gaton, M.
    Erkoreka, L.
    Zamalloa, M.
    Basterreche, N.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S653 - S654
  • [5] PALIPERIDONE-INDUCED HYPOTHERMIA
    Jones, Mary
    Kosmisky, Desiree
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 432 - 432
  • [6] Paliperidone-Induced Obsessive Symptoms
    Paparrigopoulos, Thomas
    Tzavellas, Elias
    Karaiskos, Dimitris
    Liappas, Ioannis
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2011, 23 (02) : E46 - E46
  • [7] Hyperprolactinemia due to Paliperidone Palmitate and Treatment with Aripiprazole
    Alpak, Gokay
    Unal, Ahmet
    Bulbul, Feridun
    Aksoy, Ihsan
    Demir, Bahadir
    Savas, Haluk Asuman
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 24 (03): : 253 - 256
  • [8] Paliperidone-Induced Dystonic Dysphagia
    Mendhekar, Dattatreya Namdeorao
    Agarwal, Ashish
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2010, 22 (04) : E37 - E37
  • [9] Paliperidone-induced mania: a case report
    Bal, Nese B.
    Bakir, Meryem G. Teksin
    Caykoylu, Ali
    Ozalp, Elvan
    Kocberber, Cagla
    Yilmazoglu, Bahriye E.
    ARCHIVES OF CLINICAL PSYCHIATRY, 2020, 47 (04) : 119 - 120
  • [10] Paliperidone-Induced Neuroleptic Malignant Syndrome
    Nayak, Raghavendra Bheemappa
    Bhogale, Govind S.
    Patil, Nanasaheb M.
    Chate, Sameeran S.
    Pandurangi, Aditya Anand
    Shetageri, Veda N.
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2011, 23 (01) : E14 - E15
12345